COMMUNIQUÉS West-GlobeNewswire

Telix H1 2026 Results: Investor Webcast Notification
31/07/2026
MELBOURNE, Australia and INDIANAPOLIS, July 31, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today advises that it will release its financial results for the half-year ended [...]
FocalTherics™ to Announce Second Quarter 2026 Financial Results on August 13, 2026
30/07/2026
Company to host conference call and webcast on Thursday, August 13 at 4:30 p.m. EDT FocalTherics ™ to Announce Second Quarter 2026 Financial Results on August 13, 2026 Company to host conference call and webcast on [...]
SodaSlim Official Launch 2026 Natural Weight Loss Capsules For metabolic and appetite support in USA. Soda Slim Highlights Ingredient and Supplement Facts
30/07/2026
Company Introduced SodaSlim Capsules a natural dietary supplement created to support healthy metabolism and weight management as part of a balanced lifestyle. Formulated with carefully selected ingredients and essential [...]
CooperCompanies Announces Release Date for Third Quarter 2026
30/07/2026
SAN RAMON, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will report third quarter 2026 financial results on Wednesday, September 9 [...]
Correction: Inventiva Announces Preliminary Financial Results for the First Half of 2026¹
30/07/2026
Cash and cash equivalents at €166.1 million and €67.8 million in short-term deposits 2 as at June 30, 2026 Daix (France), New York City (New York, United States), July 30, 2026 – Update to Press Release Dated July 29, [...]
Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
30/07/2026
Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod Company remains on track to submit its first New Drug Application for obefazimod for the treatment of moderately to severely active ulcerative [...]
DBV Technologies annonce le placement d’ADS pour un montant d’environ 50 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq
30/07/2026
Châtillon, France, 30 juillet 2026 DBV Technologies annonce le placement d’ADS pour un montant d’environ 50 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq DBV Technologies (la « [...]
ColestZen Launch 2026 - Healthy Cholesterol Support Formula With 18 Ingredients In (US, UK, CA, AU).ColestZen Capsule Benefits and Supplement Facts
31/07/2026
ColestZen Capsule introduces 2026 marks the introduction of a effective and healthy cholesterol support capsule formulated with a blend of 18 botanical ingredients and essential micronutrients. Designed to complement [...]
Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics
30/07/2026
Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 members Raises the midpoint of all full-year guidance [...]
Relay Therapeutics to Announce Second Quarter 2026 Financial Results and Corporate Highlights on August 6, 2026
30/07/2026
CAMBRIDGE, Mass., July 30, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living [...]
Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D.
30/07/2026
No Stockholder Action Required at This Time REDWOOD CITY, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today confirmed that [...]
Cellectis publiera ses résultats financiers du deuxième trimestre jeudi 6 août 2026
30/07/2026
NEW YORK, 30 juill. 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique qui utilise sa technologie pionnière d’édition du génome pour développer des [...]
Myriad Genetics Reports Second Quarter 2026 Financial Results; Deploying New Initiatives Focused on Driving Increased Efficiency, Productivity and Scalability
30/07/2026
Highl ights Second quarter 2026 revenue of $190.7 million decreased 11% year-over-year, reflecting a 1% decline in volume and a 9% decrease in average revenue per test year-over-year. The company is engaging payers and [...]
Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026
30/07/2026
Conference call and webcast to be held at 4:30 p.m. ET NEW HAVEN, Conn., July 30, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the [...]
Stryker reports second quarter 2026 operating results
30/07/2026
Portage, Michigan, July 30, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the second quarter of 2026: Second Quarter Results Reported net sales increased 9.4% to $6.6 billion Organic net [...]
SlimTide Official Website 2026: Launch Effective Weight Loss Formula for Healthy Digestion and Metabolism. Slim Tide capsules Highlights Ingredients, Supplement Facts.
30/07/2026
SlimTide introduces natural weight loss capsules formulated to support healthy digestion and metabolism with plant-based ingredients. Learn about the formula, key ingredients, daily use, manufacturing information, [...]
Voting Rights and Shares Capital of the Company
30/07/2026
PARIS, July 30, 2026 (GLOBE NEWSWIRE) -- In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés [...]
HAIR LOSS AWARENESS MONTH 2026: The Future of Hair Restoration Has Arrived
30/07/2026
Dr. Alan J. Bauman, board-certified Hair Restoration Physician and founder of Bauman Medical, at the practice's Boca Raton, FL Hair Hospital. Bauman Medical Highlights the New Era of AI Diagnostics, Regenerative [...]
Ipsen S.A. publie son Rapport financier semestriel 2026 (semestre clos le 30 juin 2026)
30/07/2026
Ipsen S.A. publie son Rapport financier semestriel 2026 (semestre clos le 30 juin 2026) Pièce jointe 2026 Rapport semestriel_Ipsen S.A.

Pages